Get started
Author

Bahija Jallal

Observed names: B Jallal, B. Jallal, BAHIJA JALLAL, Bahija JALLAL, Jallal, B., Jallal, Bahija
Observed institutions: Université Paris-Sud, AstraZeneca (United Kingdom), Max Planck Society, Inserm, Pfizer (United States), Istituto Superiore di Sanità, Institut Gustave Roussy, University of Chieti-Pescara, NYU Langone Health, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Infinity Pharmaceuticals (United States), Laboratoire de Biochimie, Max Planck Institute of Biochemistry, Bicêtre Hospital, Translational Sciences (United States), Institut National de la Recherche Agronomique, Novartis Institutes for BioMedical Research, Karius, Inc. (United States), Weizmann Institute of Science, New York University, University of Tübingen, Seagen (United States)
OpenAlex ID: A5071837295
Cloning and Sequencing of Porcine LH-hCG Receptor cDNA: Variants Lacking Transmembrane Domain
1989 · Hugues Loosfelt, Micheline Misrahi, et al. · Science · 558
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
2011 · Brandon W Higgs, Zheng Liu, et al. · Annals of the Rheumatic Diseases · 422
Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
1995 · C. Wallasch, F. U. Weiss, et al. · The EMBO Journal · 407
PDF
Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis
2007 · Ronan J. Walsh, Sek Won Kong, et al. · Arthritis & Rheumatism · 320
PDF
Type I Interferon: Potential Therapeutic Target for Psoriasis?
2008 · Yihong Yao, Laura Richman, et al. · PLoS ONE · 313
PDF
Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines
2002 · Marinella G. Callow, Felix Clairvoyant, et al. · Journal of Biological Chemistry · 293
PDF
Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus
2009 · Yihong Yao, Laura Richman, et al. · Arthritis & Rheumatism · 288
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
2016 · Liyan Jiang, Jiaqi Huang, et al. · PLoS Genetics · 248
PDF
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
2011 · Joan T Merrill, Daniel J Wallace, et al. · Annals of the Rheumatic Diseases · 234
Interferon‐stimulated gene 15 ( ISG15 ) conjugates proteins in dermatomyositis muscle with perifascicular atrophy
2009 · Mohammad Salajegheh, Sek Won Kong, et al. · Annals of Neurology · 207
The secreted tumor-associated antigen 90K is a potent immune stimulator
1994 · A. Ullrich, I. Sures, et al. · Journal of Biological Chemistry · 188
PDF
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
2013 · Brandon W Higgs, Wei Zhu, et al. · Annals of the Rheumatic Diseases · 173
PDF
PAK4 mediates morphological changes through the regulation of GEF-H1
2005 · Marinella G. Callow, Sergey Zozulya, et al. · Journal of Cell Science · 172
Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family.
1995 · K Mossie, B Jallal, et al. · PubMed · 160
Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis
2011 · S A Greenberg, B W Higgs, et al. · Genes and Immunity · 154
PDF
B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
2010 · Ronald Herbst, Yue Wang, et al. · Journal of Pharmacology and Experimental Therapeutics · 141
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis
2015 · Wen Pan, Shu Zhu, et al. · Nature Communications · 140
PDF
A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
2011 · K L Streicher, W Zhu, et al. · Oncogene · 139
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
2008 · Yihong Yao, Brandon W. Higgs, et al. · Human Genomics and Proteomics · 139
Type I interferons in Sjögren's syndrome
2012 · Yihong Yao, Zheng Liu, et al. · Autoimmunity Reviews · 136
PDF
Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies
2013 · Robert W. Georgantas, Katie Streicher, et al. · Arthritis & Rheumatology · 134
The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation
2002 · Ronald J Hill, Sergey Zozulya, et al. · Experimental Hematology · 134
PDF
Interaction of Vav with ENX-1, a Putative Transcriptional Regulator of Homeobox Gene Expression
1996 · Oliver Hobert, Bahija Jallal, et al. · Molecular and Cellular Biology · 130
The STE20 Kinase HGK Is Broadly Expressed in Human Tumor Cells and Can Modulate Cellular Transformation, Invasion, and Adhesion
2003 · Jocelyn H. Wright, Xueyan Wang, et al. · Molecular and Cellular Biology · 127
Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
2011 · Jin Gao, Jon W. Chesebrough, et al. · Cancer Research · 124
Works count: 141
Citation count: 8,101
H-index: 52
I10-index: 68
Year
Topic
Type